Ellis Wilson

PPD, Inc. engages in the provision of drug development services to the biopharmaceutical industry, focuses on helping customers bring their new medicines to patients around the world. It operates through the Clinical Development Services and Laboratory Services segments. The Clinical Development Services segment focuses in early development/Phase I, patient recruitment and enrollment, investigator site management, Phase II-IV clinical trial management, medical communications and various peri- and post-approval services. The Laboratory Services segment comprises of bioanalytical, vaccine sciences, GMP, central lab and biomarker testing. The company was founded by Fred Eshelma in 1985 and is headquartered in Wilmington, NC.

Wavodyne Therapeutics, Inc. develops and commercializes novel small molecule therapeutics for the treatment of memory and cognitive disorders resulting from neuro-inflammatory processes. The firm also provides research and development services. The company was founded by Jim New and is headquartered in Rochester, NY.